More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Exercise, whether moderate- or high-intensity, can help ease Parkinson's symptoms, including fatigue, new research shows. As ...

Moderate- or high-intensity exercise can help with Parkinson's disease symptoms like fatigue, a recent study shows.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

According to a study, a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson’s disease. The findings were published in the online edition of Neurology, the medical ...

The masterclass attracted over 200 delegates and showcased the holistic care model at King’s Dubai Parkinson’s Centre of ...

A new study shows that coffee is among the most commonly used "natural health products" used by people with Parkinson's ...